当前位置： SCI文献检索 > Experimental and Therapeutic Medicine期刊下所有文献 > Predictive effect of five hepatitis B virus markers on re-vaccination time of hepatitis B vaccine.

Predictive effect of five hepatitis B virus markers on re-vaccination time of hepatitis B vaccine.

Abstract：

:Examination of predictive effect of five hepatitis B virus (HBV) markers on the re-vaccination time of hepatitis B vaccine was assessed. A total of 3,243 patients examined by five HBV markers in Women and Children's Health Care Hospital of Linyi from January 2015 to December 2017 were selected as the subjects and analyzed retrospectively. According to the previous time of hepatitis B antibody vaccination, subjects were divided into three groups: Short-term group (previous time of hepatitis B vaccination <5 years, n=798); medium-term group (>5 years - ≤10 years, n=1,242); long-term group (>10 years, n=1,203). The enzyme linked immunosorbent assay was used to qualitatively analyze the five HBV markers, and chemiluminescence immunoassay was used to quantitatively analyze the five HBV markers. Hepatitis B surface antigen (HBsAg) in the long-term group and the medium-term group was significantly lower than that in the short-term group (P<0.001). HBsAg, hepatitis B e antigen, hepatitis B e antibody, hepatitis B core antibody in the long-term group was significantly higher than that in the medium-term and short-term group (P<0.050). The hepatitis B surface antibody in the long-term group was significantly lower than that in the other two groups (P<0.050). According to the previous time of the hepatitis B antibody vaccination, the patients in the long-term group were subdivided into three groups: Group A (vaccination time: 10-13 years, n=420); group B (13-15 years, n=377) and group C (>15 years, n=406). Geometric mean titer in group A was significantly lower than that in the other two groups (P<0.050). In conclusion, the protective effect of hepatitis B antibody vaccine is satisfactory for 10 years after vaccination, and re-vaccination is recommended after more than 13 years of vaccination when the virus begins to increase significantly, in order to prevent the occurrence of hepatitis B.

journal_name

Exp Ther Med

journal_title

Experimental and therapeutic medicine

authors

Jia Q,Yu F,Zhou Q,Chen X,Gu Z,Ma C

doi

10.3892/etm.2020.8859

subject

Has Abstract

pub_date

2020-08-01 00:00:00

pages

1709-1715

issue

eissn

1792-0981

issn

1792-1015

pii

ETM-0-0-8859

journal_volume

pub_type

杂志文章

在线工具

Predictive effect of five hepatitis B virus markers on re-vaccination time of hepatitis B vaccine.